Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
65.50
+2.53 (4.02%)
At close: Nov 14, 2025, 4:00 PM EST
67.00
+1.50 (2.29%)
After-hours: Nov 14, 2025, 5:56 PM EST
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $4.42 billion as of November 14, 2025. Its market cap has increased by 42.06% in one year.
Market Cap
4.42B
Enterprise Value
3.84B
1-Year Change
42.06%
Ranking
Category
Stock Price
$65.50
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $4.42B, an increase of 446.49%. That is a compound annual growth rate of 106.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 4.42B | 71.49% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |